MWNA
PGNX

Marshall Wace North America’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Marshall Wace North America’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-162,869
Closed -$1.14M – 1618
2017
Q2 		$1.14M Buy
+162,869
New +$1.14M 0.01% 906